Literature DB >> 30828782

Landmark studies in coronary heart disease epidemiology. The Framingham Heart Study after 70 years and the Seven Countries Study after 60 years.

Barbara Cybulska1, Longina Kłosiewicz-Latoszek2.   

Abstract

This year we celebrate anniversaries of two prospective studies that have contributed most to our understanding of the epi-demiology of coronary heart disease (CHD): the Framingham Heart Study (FHS) and the Seven Countries Study (SCS). The FHS was initiated 70 years ago and is continued in the subsequent generations using new research opportunities, including evaluation of the risk factors for chronic non-cardiovascular diseases. The SCS is now finished because the original study population are mostly deceased, and the study did not continue in the children and grandchildren of the participants. The FHS allowed identification of factors predisposing to CHD, which were referred to as "risk factors" for the first time. Based on the FHS findings, a multivariate model of the 10-year CHD risk was developed, known as the Framingham Heart Score. In addition, criteria of heart failure and risk factors for atrial fibrillation were defined. The SCS provided the first evidence for an association between nutrition and CHD and laid the foundations for recommending the Mediterranean diet for cardio-vascular disease prevention.

Entities:  

Keywords:  Framingham Heart Study; Seven Countries Study; achievements; history

Mesh:

Year:  2019        PMID: 30828782     DOI: 10.5603/KP.a2019.0017

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


  7 in total

1.  The value of N-terminal pro-brain natriuretic peptide and hs-CRP in predicting acute kidney injury after acute myocardial infarction.

Authors:  Wenfeng Wang; Yuanxing Xie; Xuebing Huang; Yan Zhou; Lei Luo
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

2.  Correlation between the elevated uric acid levels and circulating renin-angiotensin-aldosterone system activation in patients with atrial fibrillation.

Authors:  Xue-Dong Wang; Jing Liu; Yu-Chen Zhang; Yu Wang; Yan Wang; Dan Ma
Journal:  Cardiovasc Diagn Ther       Date:  2021-02

3.  Downregulation of Uncoupling Protein 2(UCP2) Mediated by MicroRNA-762 Confers Cardioprotection and Participates in the Regulation of Dynamic Mitochondrial Homeostasis of Dynamin Related Protein1 (DRP1) After Myocardial Infarction in Mice.

Authors:  Dehui Liu; Shangrong Zou; Guangnan Li; Qiyu Zhang; Chunlin Chen; Cuizhi Li; Huafeng Song; Shaoxian Chen; Jiawen Wang; Yueheng Wu; Youbin Liu
Journal:  Front Cardiovasc Med       Date:  2022-02-24

4.  A high-throughput and untargeted lipidomics approach reveals new mechanistic insight and the effects of salvianolic acid B on the metabolic profiles in coronary heart disease rats using ultra-performance liquid chromatography with mass spectrometry.

Authors:  Ying-Peng Li; Cong-Ying Wang; Hong-Tao Shang; Rui-Rui Hu; Hui Fu; Xue-Feng Xiao
Journal:  RSC Adv       Date:  2020-05-01       Impact factor: 4.036

5.  The Expression Significance of LPa, BNP, and McP-1 in CHD Patients and Their Relationship with Echocardiographic Parameters.

Authors:  Yunpeng Ma; Yinzun Qi; Qiang Li; Shuangxiong Zhu; Wenjie Zhao; Yu Zhang
Journal:  Contrast Media Mol Imaging       Date:  2022-08-27       Impact factor: 3.009

6.  Intracoronary Ultrasound Imaging Combined with Traditional Chinese Medicine Nursing Applied in the Treatment of Coronary Heart Disease Patients with Phlegm and Blood Stasis Syndrome.

Authors:  Hui Zeng; Chunmian Guo; Yan Yang; Xia Chu; Yanru Shi
Journal:  Contrast Media Mol Imaging       Date:  2022-08-21       Impact factor: 3.009

7.  Effect of CICARE Communication Mode on Disease Uncertainty, Self-Nursing Ability, and Quality of Life in Patients with Coronary Atherosclerotic Heart Disease after Percutaneous Coronary Intervention.

Authors:  Hui Hu; Ayong Zhang; Zhen Wang
Journal:  Comput Math Methods Med       Date:  2022-08-05       Impact factor: 2.809

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.